U.S. flag

An official website of the United States government

NM_000360.4(TH):c.1228C>T (p.Arg410Trp) AND Autosomal recessive DOPA responsive dystonia

Germline classification:
Conflicting interpretations of pathogenicity (5 submissions)
Last evaluated:
Jan 30, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000695395.12

Allele description [Variation Report for NM_000360.4(TH):c.1228C>T (p.Arg410Trp)]

NM_000360.4(TH):c.1228C>T (p.Arg410Trp)

Gene:
TH:tyrosine hydroxylase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.5
Genomic location:
Preferred name:
NM_000360.4(TH):c.1228C>T (p.Arg410Trp)
HGVS:
  • NC_000011.10:g.2165338G>A
  • NG_007114.1:g.857C>T
  • NG_008128.1:g.11468C>T
  • NG_050578.1:g.872C>T
  • NM_000360.4:c.1228C>TMANE SELECT
  • NM_199292.3:c.1321C>T
  • NM_199293.3:c.1309C>T
  • NP_000351.2:p.Arg410Trp
  • NP_954986.2:p.Arg441Trp
  • NP_954987.2:p.Arg437Trp
  • NC_000011.9:g.2186568G>A
  • NM_199292.2:c.1321C>T
Protein change:
R410W
Links:
dbSNP: rs575326605
NCBI 1000 Genomes Browser:
rs575326605
Molecular consequence:
  • NM_000360.4:c.1228C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_199292.3:c.1321C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_199293.3:c.1309C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Autosomal recessive DOPA responsive dystonia
Synonyms:
Segawa syndrome, autosomal recessive; DYT-TH; TH-deficient dopa-responsive dystonia; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0011551; MedGen: C2673535; Orphanet: 101150; OMIM: 605407

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000823892Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 30, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV002091035Natera, Inc.
no assertion criteria provided
Uncertain significance
(Mar 6, 2020)
germlineclinical testing

SCV002792035Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Oct 28, 2021)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004203841Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 11, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004238760Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Apr 11, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype.

Haugarvoll K, Bindoff LA.

J Parkinsons Dis. 2011;1(1):119-22. doi: 10.3233/JPD-2011-11006.

PubMed [citation]
PMID:
23939262

A novel tyrosine hydroxylase variant in a group of Chinese patients with dopa-responsive dystonia.

Yan YP, Zhang B, Mao YF, Guo ZY, Tian J, Zhao GH, Pu JL, Luo W, Ouyang ZY, Zhang BR.

Int J Neurosci. 2017 Aug;127(8):694-700. doi: 10.1080/00207454.2016.1236381. Epub 2016 Oct 5.

PubMed [citation]
PMID:
27619486
See all PubMed Citations (4)

Details of each submission

From Invitae, SCV000823892.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 441 of the TH protein (p.Arg441Trp). This variant is present in population databases (rs575326605, gnomAD 0.1%). This missense change has been observed in individual(s) with clinical features of TH-related dystonia (PMID: 27619486; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 573670). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TH protein function. This variant disrupts the p.Arg441 amino acid residue in TH. Other variant(s) that disrupt this residue have been observed in individuals with TH-related conditions (PMID: 23939262, 27619486), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002091035.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Fulgent Genetics, Fulgent Genetics, SCV002792035.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004203841.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Revvity Omics, Revvity, SCV004238760.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 16, 2024